
| 2 min read
New study uses simulations and machine learning to identify a single, high-impact interaction within a viral fusion protein, highlighting a potential new target for antiviral drug development.
| 9 min read
Rather than replacing radiologists, AI is working alongside them to catch cancers earlier and improve screening efficiency.
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 7 min read
They’re approved by the FDA and Medicare and inching closer to widespread adoption nationally. But how good are they at detecting colorectal cancer?News
Cancer Research News
QDX and Prelude Therapeutics are developing drugs that selectively target the JAK2 V617F mutation, offering hope for patients with myeloproliferative neoplasms.
Scientists created a novel platform that uses the advantages of both bacteria and viruses to attack tumors.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation.
Discover how supercritical fluids expand chromatographic capabilities across diverse analytical challenges.



















